Meet the German Capital Region at BIO International Convention in San Diego, June 13-18, San Diego Convention Center | German Pavilion | Booth #4617

Berlin / Nijmegen, 8 April 2022. Radboud University Medical Center (RUMC) in Nijmegen, one of the largest centres of excellence in the Netherlands for adrenal diseases, treated the first patient with primary aldosteronism with the Ga-68-based…

Study published in Nature shows mental disorder associated with specific genes

We proudly announce the Speed Lecture Award finalists in 2022 that had been selected by the jury. Congratulations to all of them and good luck for your final performance on May 11th at Urania Berlin!

Potsdam (Germany), 05.04.2022. The Potsdam-based company Data4Life is expanding its research activities around the collection of real-world data. In January 2022, the non-profit organization launched the digital female health study FeMFit…

Presentation at ACC.22 shows early treatment of high-risk NSTEMI patients guided by continuous arrhythmia monitoring with ICMs may reduce major adverse cardiac events (MACE)

Berlin, 30 March 2022. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) achieved sales of EUR 180.4 million in fiscal year 2021 (previous year: EUR 176.1 million). The consolidated net income for the year reached a new…

Planned investments of around €2bn over next three years / Shift of resources into strategic pharmaceutical areas by investing in key production sites, manufacturing technologies and supply chain network / Bayer is transforming its pharmaceutical…

BIOTRONIK Patient App is available for patients with a compatible BIOTRONIK cardiac device

Berlin, 23 March 2022. Eckert & Ziegler (ISIN DE0005659700, TecDAX) has executed with the Canadian biotech company Alpha-9 Theranostics Inc. (Alpha-9) a clinical supply agreement for Eckert & Ziegler's medical radioisotope Lutetium-177…